3-Chloro-PCP, also known as 3′-Cl-PCP, is a synthetic designer drug classified within the arylcyclohexylamine family. It is renowned for its dissociative effects. While it exhibits potency similar to phencyclidine (PCP), it offers a slightly distinct effects profile. Specifically, it is recognized for its enhanced potency as an NMDA antagonist while maintaining a comparable strength as a dopamine reuptake inhibitor. This compound was first detected in Slovenia in December 2020 and was subjected to legal restrictions in Hungary in April 2021.

IUPAC name
CAS Number2201-32-3 
PubChem CID125502037
Chemical and physical data
Molar mass277.84 g·mol−1


1. What is 3-Chloro-PCP (3′-Cl-PCP)?

  • 3-Chloro-PCP, often referred to as 3′-Cl-PCP, is a synthetic designer drug belonging to the arylcyclohexylamine family. It is known for its dissociative effects and is structurally related to phencyclidine (PCP).

2. How is 3′-Cl-PCP typically used?

  • 3′-Cl-PCP is primarily used for recreational purposes. It can be consumed orally, inhaled, or insufflated (snorted). The specific method of use may vary among individuals.

3. What are the effects of 3′-Cl-PCP?

  • The effects of 3′-Cl-PCP are characterized by dissociation, altered perception of reality, and a sense of detachment from one’s surroundings. It has a similar profile to phencyclidine but with some distinct differences.

4. Is 3′-Cl-PCP legal?

  • Legal status varies by country and jurisdiction. As of April 2021, it has been made illegal in Hungary. Users should be aware of the laws in their specific area regarding the possession and use of this substance.

5. Is 3′-Cl-PCP safe to use?

  • The safety of using 3′-Cl-PCP is a subject of concern, as its long-term effects and potential risks are not well-documented. Like many designer drugs, there can be health risks associated with use, including unknown purity and possible adverse reactions.

6. What are the risks and side effects of using 3′-Cl-PCP?

  • Common side effects may include nausea, disorientation, hallucinations, and impaired motor skills. Overdosing can lead to more severe symptoms such as anxiety, confusion, and potentially life-threatening conditions.

7. Can 3′-Cl-PCP be addictive?

  • There is a potential for psychological dependence with repeated use, but it is not considered highly physically addictive like some other substances.

8. How can I reduce the risks associated with 3′-Cl-PCP use?

  • If you choose to use 3′-Cl-PCP, it’s essential to start with a low dose, be in a safe environment, and have someone you trust present. Avoid mixing it with other substances and be aware of its potential adverse effects.

9. Is there a safe or recommended dosage for 3′-Cl-PCP?

  • The dosage can vary based on an individual’s tolerance and experience. Starting with a low dose and monitoring your body’s response is advisable.

10. Where can I find help or support for 3′-Cl-PCP-related issues?

  • If you or someone you know is struggling with substance use or addiction, it’s crucial to seek professional help. Reach out to addiction treatment centers or healthcare providers for guidance and support.

11. Are there any medical or therapeutic uses for 3′-Cl-PCP?

  • 3′-Cl-PCP is not approved for medical use and should not be considered a substitute for prescribed medications or treatments.

Please note that this information is for informational purposes only, and the use of designer drugs like 3′-Cl-PCP carries risks and legal implications. Always prioritize your health and safety, and be aware of the laws in your area.


  1. In 2020, Catalani V, Arillotta D, Corkery JM, Guirguis A, Vento A, and Schifano F conducted research titled “Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach.” This study was published in Frontiers in Psychiatry, Volume 11, and can be accessed via DOI: 10.3389/fpsyt.2020.632405. It is also available on PMC with reference number 7900492 and PMID: 33633599.
  2. The National Forensic Laboratory in Slovenia produced an analytical report on “3Cl-PCP (C17H24ClN),” specifically identified as “1‐[1‐(3‐chlorophenyl)cyclohexyl]piperidine.” This report can be found in PDF format and provides valuable information regarding this psychoactive substance.
  3. The “Amendment of Minister for Human Capacities Decree No 55/2014 on substances or groups of compounds classified as new psychoactive substances, 2021/225/HU” was issued by the Minister for Human Capacities. This amendment, dated December 30, 2014, plays a significant role in regulating substances in Hungary and their classification as new psychoactive substances.

Leave a Comment

Your email address will not be published. Required fields are marked *